Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Sep 2026.
- Largest single sale: $550K (6,539 shares) of Dexcom on Sep 15, 2026. Filing
- Last sale before this period: Jun 16, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dexcom (DXCM) | Director | Nov 25, 2009 | Sep 16, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 15, 2026, Dexcom: sold 6,539 shares for $550K, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 14, 2026, Dexcom: sold 1,550 shares for $130K, under a disclosed plan (some held indirectly). 1 filing: 1
- Aug 12, 2026, Dexcom: 1,075 shares given away (some held indirectly). 1 filing: 1
- May 28, 2026, Dexcom: 5,575 shares granted. 1 filing: 1
- May 8, 2026, Dexcom: 10,092 shares moved between their own holdings (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.